Intravenous bisphosphonates in osteoporosis and jaw osteonecrosis: comment on the article by Delmas et al.
Landis
Basile N
BN
Hugentobler
Max
M
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D007568:Jaw; D010020:Osteonecrosis / Q000139:chemically induced*; D010024:Osteoporosis / Q000188:drug therapy*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates